ConductScience.org, home

Trial · NCT04927013

Connecting Families to Overcome Ovarian Cancer

NCT04927013, Not applicable, Completed, Emory University; results first posted 2024-10-03

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Connecting Families to Overcome Ovarian Cancer. Trials, record NCT04927013. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04927013

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Connecting Families to Overcome Ovarian Cancer
NCT number
NCT04927013
Status
Completed
Phases
Not applicable
Enrollment
2,331 participants, actual
Lead sponsor
Emory University
Conditions
Ovarian Cancer
Interventions
Message-based Outreach Intervention for Survivors, Standard Outreach for Survivors, Message-based Outreach Intervention for Close Relatives, Standard Outreach for Close Relatives
First posted
2021-06-15
Last updated
2024-10-03
Results first posted
2024-10-03

Source ClinicalTrials.gov

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Survivors Using Website Access CodeUp to 19 monthsSurvivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who used their unique login to access the study website.
PrimaryNumber of Survivors Consenting to Participate in the StudyUp to 19 months
Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who used their unique login code to access the study website and consented to participate in the study while visiting the website.
PrimaryNumber of Survivors Creating a Study LoginUp to 19 months
Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who access the study website, consented to participate in the study, and created their own personal study login on the website.
PrimaryNumber of Relatives of Survivors Using the Website Access CodeUp to 19 monthsClose relative reach is assessed as the number of close relatives enumerated by survivors who used their unique login code to access the study website.
PrimaryNumber of Relatives of Survivors Consenting to Participate in the StudyUp to 19 monthsClose relative reach is assessed as the number of close relatives enumerated by survivors who accessed the website and consented to participate in the study while they were using the website.
PrimaryNumber of Relatives of Survivors Creating a LoginUp to 19 months
Close relative reach is assessed as the number of close relatives enumerated by survivors who accessed the study website, gave consent to participate in the study, and created their own personal study login on the study website.
SecondaryRelative Contact Option Selected by SurvivorsUp to 19 months
Cancer survivors in the Message-based Outreach Intervention arm who accessed the website were asked to enumerate close relatives and choose from a menu of options about how the survivor would prefer for their relatives to be contacted.
SecondaryNumber of Survivors Requesting Telegenetic CounselingUp to 19 monthsThe request rate of cancer genetic services is assessed as the number of cancer survivors who requested telegenetic counseling on the website.
SecondaryNumber of Survivors Completing Telegenetic CounselingUp to 19 monthsUptake of cancer genetic services is assessed as the number of survivors who completed telegenetic counseling.
SecondaryNumber of Relatives Requesting Telegenetic CounselingUp to 19 monthsThe request rate of cancer genetic services is assessed as the number of close relatives who requested telegenetic counseling on the website.

Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Survivors Using Website Access CodeUp to 19 monthsParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Survivors Consenting to Participate in the StudyUp to 19 monthsThe analysis population includes individuals who used their unique login code to access the study website.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Survivors Creating a Study LoginUp to 19 monthsThe analysis population includes individuals who gave consent to participate in the study.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Relatives of Survivors Using the Website Access CodeUp to 19 monthsThe analysis population includes close relatives of cancer survivors who were identified by the survivors to be contacted and offered the opportunity to participate in the study.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Relatives of Survivors Consenting to Participate in the StudyUp to 19 monthsThe analysis population includes close relatives who accessed the study website.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYNumber of Relatives of Survivors Creating a LoginUp to 19 monthsThis analysis population includes close relatives who gave consent to participate in the study.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYRelative Contact Option Selected by SurvivorsUp to 19 months
This analysis population includes cancer survivors who accessed the website and selected a contact method for the close relatives that they provided contact information for. Survivors could identify more than one close relative and some did not identify any relatives.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Survivors Requesting Telegenetic CounselingUp to 19 monthsThis analysis includes participants who accessed the study website.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Survivors Completing Telegenetic CounselingUp to 19 monthsThis analysis includes participants who requested telegenetic counseling on the website.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Relatives Requesting Telegenetic CounselingUp to 19 monthsThis analysis population includes close relatives who gave consent to participate in the study.ParticipantsCOUNT_OF_PARTICIPANTS

Results by group29

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Survivors Using Website Access CodeMessage-based Outreach Intervention (MBI) for Survivors147Participants
Number of Survivors Using Website Access CodeStandard Outreach for Survivors202Participants
Number of Survivors Consenting to Participate in the StudyMessage-based Outreach Intervention (MBI) for Survivors130Participants
Number of Survivors Consenting to Participate in the StudyStandard Outreach for Survivors184Participants
Number of Survivors Creating a Study LoginMessage-based Outreach Intervention (MBI) for Survivors126Participants
Number of Survivors Creating a Study LoginStandard Outreach for Survivors174Participants
Number of Relatives of Survivors Using the Website Access CodeMessage-based Outreach Intervention for Close Relatives20Participants
Number of Relatives of Survivors Using the Website Access CodeStandard Outreach for Close Relatives1Participants
Number of Relatives of Survivors Consenting to Participate in the StudyMessage-based Outreach Intervention for Close Relatives19Participants
Number of Relatives of Survivors Consenting to Participate in the StudyStandard Outreach for Close Relatives1Participants

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDMessage-based Outreach Intervention (MBI) for Survivors969
Overall StudySTARTEDStandard Outreach for Survivors969
Overall StudySTARTEDMessage-based Outreach Intervention for Close Relatives152
Overall StudySTARTEDStandard Outreach for Close Relatives241
Overall StudyCOMPLETEDMessage-based Outreach Intervention (MBI) for Survivors130
Overall StudyCOMPLETEDStandard Outreach for Survivors184
Overall StudyCOMPLETEDMessage-based Outreach Intervention for Close Relatives19
Overall StudyCOMPLETEDStandard Outreach for Close Relatives1
Overall StudyNOT COMPLETEDMessage-based Outreach Intervention (MBI) for Survivors839
Overall StudyNOT COMPLETEDStandard Outreach for Survivors785

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals12

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityMessage-based Outreach Intervention (MBI) for Survivors0969
Total, all-cause mortalityStandard Outreach for Survivors0969
Total, all-cause mortalityMessage-based Outreach Intervention for Close Relatives0152
Total, all-cause mortalityStandard Outreach for Close Relatives0241
Total, other adverse eventsMessage-based Outreach Intervention (MBI) for Survivors0969
Total, other adverse eventsStandard Outreach for Survivors0969
Total, other adverse eventsMessage-based Outreach Intervention for Close Relatives0152
Total, other adverse eventsStandard Outreach for Close Relatives0241
Total, serious adverse eventsMessage-based Outreach Intervention (MBI) for Survivors0969
Total, serious adverse eventsStandard Outreach for Survivors0969

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
38912902RESULTPubMed
40327861DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
U01CA240581Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic ServicesGUAN, YUEEMORY UNIVERSITYNATIONAL CANCER INSTITUTE2020 to 2023

Trial comparisons9

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Consenting to Participate in the StudyTrial comparisons
Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Creating a Study LoginTrial comparisons
Message-based Outreach Intervention for Close Relatives vs Standard Outreach for Close Relatives: Number of Relatives of Survivors Using the Website Access CodeTrial comparisons
Message-based Outreach Intervention for Close Relatives vs Standard Outreach for Close Relatives: Number of Relatives of Survivors Consenting to Participate in the StudyTrial comparisons
Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Completing Telegenetic CounselingTrial comparisons
Message-based Outreach Intervention for Close Relatives vs Standard Outreach for Close Relatives: Number of Relatives Requesting Telegenetic CounselingTrial comparisons
Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Using Website Access CodeTrial comparisons
Message-based Outreach Intervention for Close Relatives vs Standard Outreach for Close Relatives: Number of Relatives of Survivors Creating a LoginTrial comparisons
Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Requesting Telegenetic CounselingTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04927013

GET https://conductscience.org/api/trials/v1/NCT04927013/results?page=2